Trending event

David Ferrera, a partner in the Litigation Department and chair of the Product Liability Litigation practice group, spoke at the American Bar Association’s (ABA) “Current Issues in Pharmaceutical and Medical Device Litigation,” sponsored by the Pharmaceutical and Medical Device Subcommittees of the Products Liability Committee and the Mass Torts Committee of the ABA Section of Litigation, on November 16. David presented on the panel “Hot Topics and Recent Developments in Medical Device Regulation and Enforcement” and his particular topic focused on evolving FDA requirements on post market surveillance and Section 522 studies and what recent FDA actions in this area mean for companies.